Originalarbeiten

1. Jordi SBU, Lang BM, Wyss J, Auschra B, Bahtiyar Y, Krupka N, Greuter T, Schreiner Ph, Biedermann L, Preisig M, von Känel R, Rogler G,  Begré and Misselwitz B on behalf of the Swiss IBD cohort study group. The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patientsJ Gastroenterol. 2022 Nov;57(11):848-866.
2. Jordi SBU, Lang BM, Auschra B, von Känel R, Biedermann L, Greuter T, Schreiner Ph, Rogler G, Krupka N, Sulz MCH, Misselwitz B and Begré S on behalf of the Swiss IBD cohort study group. Depressive symptoms predict clinical recurrence of inflammatory bowel disease. Inflamm Bowel Dis. 2022 Mar 30;28(4):560-571.
3. Jordi SBU, Botte F, Lang BM, Greuter T, Krupka N, Auschra B, Schreiner Ph, Sulz MCH, Biedermann L, von Känel R, Rogler R, Begré S and Misselwitz B on behalf of the Swiss IBD cohort study group. Type D personality is associated with depressive symptoms and clinically active disease in inflammatory bowel disease. Aliment Pharmacol Ther. 2021 Jul;54(1):53-67.
4. Ledergerber M, Lang BM, Heinrich H, Biedermann L, Begré S, Zeitz J, Krupka N, Rickenbacher A, Turina M, Greuter T, Schreiner P, Roth R, Siebenhüner A, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B; Swiss IBD Cohort Study Group. Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management. BMC Gastroenterol. 2021 Feb 5;21(1):53.
5. Humbel F, Rieder JH, Franc Y, Juillerat P, Scharl M, Misselwitz B, Schreiner Ph, Begré S, Macpherson AJ, Rogler G, von Känel R, Yilmaz B, Biedermann L; Swiss IBD Cohort Study Group. Association of Mucosa-Associated Microbial Alterations with Anxiety, Depression, Perceived Stress and Decreased Quality of Life in IBD Patients in Remission. Clin Gastroenterol Hepatol. 2020 Aug;18(9):2019-2029.
6. Cernoch PS, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss Cohort Study Group. Lower Ris of B1-to-pB3-Stage Migration in Crohn’s Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study. Dig Dis Sci. 2020 Sep;65(9):2654-2663
7. Pillai N, Lupatsch JE, Dusheiko M, Schwenkglenks M, Maillard M, Sutherland CS, Pittet VEH; Swiss IBD Cohort Study group. Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn’s Disease using Real-World Data. J Crohns Colitis. 2020 May 21;14(4):490-500.
8. Pittet VEH, Maillard MH, Simonson T, Fournier N, Rogler G, Michetti P; Swiss IBD Cohort Study Group. Differences in Outcomes Reported by Patients with Inflammatory Bowel Diseases vs Their Health Care Professionals. Clin Gastroenterol Hepatol. 2019 Sep;17(10):2050-2059
9. Pittet V, Michetti P, Mueller C, Braegger CP, von Känel R, Schoepfer A, Macpherson AJ, Rogler G; Swiss IBD Cohort Study Group. Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol. 2019 Apr 1;48(2):385-386f.
10. Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group. Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-Year Follow-up Data from the Swiss IBD Cohort Study. J Crohns Colitis. 2018 Jun 28;12(7):811-818.
11. Madanchi M, Fagagnini S, Fournier N, Biedermann L, Zeitz J, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M; Swiss IBD Cohort Study Group. The Relevance of Vitamin and Iron Deficiency in patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort. Inflamm Bowel Dis. 2018 Apr 13.
12. Lang BM, Biedermann L, van Haaften WT, de Vallière C, Schuurmans M, Begré S, Zeitz J, Scharl M, Turina M, Greuter T, Schreiner P, Heinrich H, Kuntzen T, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B; Swiss IBD Cohort Study Group. Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn’s disease. Aliment Pharmacol Ther. 2018 Jan;47(1):55-66.
13. Mikocka-Walus A, Pittet V, Rossel JB, von Känel R; Swiss IBD Cohort Study Group. Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2016 Jun;14(6):829-835.
14. Mueller R, Ziade F, Pittet V, Fournier N, Ezri J, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study Group. Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way? J Crohns Colitis 2016;10(3)d:269-76.
15. Safroneeva E, Vavricka SR, Fournier N, Pittet V, Peyrin-Biroulet L, Straumann A, Rogler G, Schoepfer AM; Swiss IBD Cohort Study Group. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn’s disease. Aliment Pharmacol Ther. 2015 Oct;42(8):977-89.
16. Safroneeva E, Vavricka S, Fournier N, Seibold F, Mottet C, Nydegger A, Ezri J, Straumann A, Rogler G, Schoepfer AM; Swiss IBD Cohort Study Group. Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients. Aliment Pharmacol Ther. 2015 Sep;42(5):540-8. doi: 10.1111/apt.13307. Epub 2015 Jul 6. Erratum in: Aliment Pharmacolt her. 2015;42(11-12):1334.
17. Hiroz P, Vavricka SR, Fournier N, Safroneeva E, Pittet V, Rogler G, Schoepfer AM; Swiss Inflammatory Bowel Diseases Cohort Study Group. Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort. Scand J Gastroenterol. 2014 Oct;49(10):1207-18
18. Violi NV, Schoepfer AM, Fournier N, Guiu B, Bize P, Denys A; Swiss Inflammatory Bowel Disease Cohort Study Group. Prevalence and clinical importance of mesenteric venous thrombosis in the Swiss Inflammatory Bowel Disease Cohort. AJR Am J Roentgenol. 2014 Jul;203(1):62-9.
19. Schaffer T, Schoepfer AM, Seibold F; Swiss IBD Cohort Study Group. Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn’s disease activity. J Crohns Colitis. 2014 Sep 1;8(9):1125-32
20. Maillard MH, Bortolotti M, Vader JP, Mottet C, Schoepfer A, Gonvers JJ, Burnand B, Froehlich F, Michetti P, Pittet V; Swiss IBD Cohort Study Group. Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis. J Crohns Colitis. 2014 Aug 1;8(8):825-34
21. Schoepfer AM, Dehlavi MA, Fournier N, Safroneeva E, Straumann A, Pittet V, Peyrin-Biroulet L, Michetti P, Rogler G, Vavricka SR; IBD Cohort Study Group. Diagnostic delay in Crohn’s disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol. 2013 Nov;108(11):1744-53
22. Pittet V, Rogler G, Michetti P, Fournier N, Vader JP, Schoepfer A, Mottet C, Burnand B, Froehlich F; Swiss Inflammatory Bowel Disease Cohort Study Group. Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn’s disease. Digestion. 2013;87(3):212-21
23. Sulz MC, Siebert U, Arvandi M, Gothe RM, Wurm J, von Känel R, Vavricka SR, Meyenberger C, Sagmeister M; Swiss IBD Cohort Study Group. Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study. Eur J Gastroenterol Hepatol. 2013 Jul;25(7):790-7
24. Siebert U, Wurm J, Matteucci Gothe R, Arvandi M, Vavricka SR, von Känel R, Begré S, Sulz MC, Meyenberger Ch, Sagmeister M, and the Swiss IBD Cohort Study Group. Predictors of Temporary and Permanent Work Disability in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2013 Feb 26
25. Eloranta JJ, Wenger C, Mwinyi J, Hiller C, Gubler C, Vavricka SR, Fried M, Kullak-Ublick GA; Swiss IBD Cohort Study Group. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenet Genomics. 2011 Sep;21(9):559-64.
26. Braegger CP, Ballabeni P, Rogler D,Vavricka SR,Friedt M, Pittet V; Swiss IBD Cohort Study Group. Epidemiology of inflammatory bowel disease: is there a shift towards onset at a younger age? J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):141-4.
27. Von Känel R, Hari R, Schmid JP, Saner H, Begré S. Distress related to myocardial infarction and cardiovascular outcome: a retrospective observational study. BMC Psychiatry 2011, Jun 10;11(1):98
28. Cámara RJA, Lukas PS, Begré S, von Känel R. Effects of social support on the clinical course of Crohn’s disease. Inflamm Bowel Dis. 2011 Jun;17(6):1277-86
29. Von Känel R, Hari R, Schmid JP, Wiedemar L, Guler E, Saner H, Schnyder U, Begré S. Non-fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction. J Cardiol. 2011 Jul;58(1):61-8
30. Cámara RJ, Juillerat P, Pittet V, Schoepfer AM, Begré S, von Känel R. Quality of life: a potential useful measure to indicate subclinical flares in Crohn’s Disease. Internal Medicine Journal Intern Med J. 2012.Jul;42(7)
31. Cámara RJA, Schoepfer AM, Pittet V, Begré S, von Känel R; Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) Group. Mood and Non-Mood Components of Perceived Stress and Exacerbation of Crohn’s Disease. Inflamm Bowel Dis. 2011 Nov;17(11):2358-65.
32. Cámara RJA, Gander ML, Begré S, von Känel R. Posttraumatic stress on the clinical course in Crohn’s disease. Frontline Gastroenterol 2011 Jan;2(1):2-9.
33. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. Voegtlin M, Vavricka SR, Schoepfer AM, Straumann A, Voegtlin J, Rogler G, Ballabeni P, Pittet V, Buser A, Fried M, Beglinger C; Swiss IBD Cohort Study group. J Crohns Colitis. 2010 Dec;4(6):642-8.
34. Cámara RJ, Begré S, von Känel R. Avoidance And Inhibition do Not Predict Non-Respondent Bias in Inflammatory Bowel Disease J Epidemiol. 2011;21(1):44-51
35. Infliximab for Crohn’s disease in the Swiss IBD Cohort Study: clinical management and appropriateness. Juillerat P, Pittet V, Vader JP, Burnand B, Gonvers JJ, de Saussure P, Mottet C, Seibold F, Rogler G, Sagmeister M, Felley C, Michetti P, Froehlich F; Swiss IBD Cohort Study Group. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1352-7.
36. Appropriateness of therapy for fistulizing Crohn’s disease: findings from a national inflammatory bowel disease cohort. Pittet V, Juillerat P, Michetti P, Vader JP, Burnand B, Rogler G, Beglinger C, Seibold F, Mottet C, Felley C, Gonvers JJ, Froehlich F; Swiss IBD Cohort Study Group. Aliment Pharmacol Ther. 2010 Oct;32(8):1007-16.
37. Hari R, Begré S, Schmid JP, Saner H, Gander ML, von Känel R. Change Over Time in Posttraumatic Stress Caused by Myocardial Infarction and Predicting Variables. J Psychosom Res. 2010 Aug;69(2):143-50
38. Begré S, Traber M, Gerber M, von Känel R. Charakteristika chronischer Schmerzpatienten mit depressiver Begleitsymptomatik in drei unterschiedlichen Behandlungssettings. Med Klin (Munich). 2010 Jun;105(6):393-8.
39. Von Känel R, Abbas CC, Begré S, Saner H, Gander ML, Schmid JP. Posttraumatic Stress Disorder to Soluble Cellular Adhesion Molecules at Rest and to a Trauma-Specific Interview in Patients after Myocardial Infarction. Psychiatry Res. 2010 Oct 30;179(3):312-7
40. Begré S, Traber M, Gerber M, von Känel R. Physician Speciality and Pain Reduction in Patients with Depressive Symptoms under Treatment with Venlafaxine. Eur Psychiatry. 2010 Dec;25(8):455-60
41. Von Känel R, Abbas Ch C, Schmid JP, Saner H, Haeberli A, Stutz M, Begré S. Momentary Stress Moderates Procoagulant Reactivity to a Trauma-specific Interview in Patients With Posttraumatic Stress Disorder Caused by Myocardial Infarction. J Psychiatr Res. 2010 Oct;44(14):956-63
42. Krummenacher R, Lukas P, Demarmels Biasiutti F, Begré S, Znoj H, von Känel R. Relationship Between Psychological Distress and Endogenous Anticoagulants in Patients With a Previous Venous Thromboembolic Event. Clin Appl Thromb Hemost. 2011 Apr;17(2):171-80
43. Von Känel R, Krämer B, Saner H, Schmid JP, Abbas CC, Begré S. Posttraumatic Stress Disorder and Dyslipidemia: Previous Research and Novel Findings From Patients With PTSD Caused by Myocardial Infarction. World J Biol Psychiatry. 2010 Mar;11(2):141-7
44. Von Känel R, Abbas CC, Begré S, Gander ML, Saner H, Schmid JP. Association between Posttraumatic Stress Disorder Following Myocardial Infarction and Liver Enzyme Levels: A Prospective Study. Dig Dis Sci. 2010 Sep;55(9):2614-23
45. LukasP, Krummenacher R, Demarmels Biasiutti F, Begré S, Znoj H, von Känel R. Association of Fatigue and Psychological Distress With Quality of Life in Patients With a Previous Venous Thromboembolic Event. Thromb Haemost. 2009 Dec;102(6):1219-26.
46. Krummenacher R, LukasP, Demarmels Biasiutti F, Begré S, Znoj H, von Känel R. Independent Association of Sleep Quality, Fatigue, and Vital Exhaustion with Platelet Count in Patients with a Previous Venous Thromboembolic Event. Platelets. 2009 Dec;20(8):566-74.
47. Von Känel R, Begré S, Abbas CC, Saner H, Gander ML, Schmid JP. Inflammatory Biomarkers in patients with posttraumatic stress disorder caused by myocardial infarction and the role of depressive symptoms. Neuroimmunomodulation. 2010;17(1):39-46.
48. Von Känel R, Schmid JP, Abbas CC, Gander ML, Saner H, Begré S. Stress hormones in patients with posttraumatic stress disorder caused by myocardial infarction and role of comorbid depression. J Affect Disord. 2010 Feb;121(1-2):73-9.
49. Begré S, Kiefer C, von Känel R, Frommer A, Federspiel. Rey Visual Design Learning Test Performance Correlates With White Matter Structure. Acta Neuropsychiatrica 2009: 21(2): 67–74.
50. Begré S, Traber M, Gerber M, von Känel R. Regional Origin on Decrease of Pain in Patients with Depressive Symptoms under Treatment with Venlafaxine. Soc Psychiatry Psychiatr Epidemiol. 2010 Jan;45(1):17-24.
51. Abbas CC, Schmid JP, Guler E, Wiedemar L, Begré S, Saner H, Schnyder U, von Känel R. Trajectory of Posttraumatic Stress Disorder Caused by Myocardial infarction: A Two-Year Follow-up Study. Int J Psychiatry Med 2009;39(4):359-376.
52. Begré S, Kleinlogel H, Kiefer C, Strik W, Dierks T, Federspiel A. White Matter Anisotropy related to Electrophysiology of First Episode Schizophrenia during NoGo Inhibition. Neurobiol Dis. 2008 May;30:270-80.
53. Begré S, Traber M, Gerber M, von Känel R. Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: An observational study in primary care. Eur Psychiatry. 2008 Apr;23(3):178-86.
54. Begré S, Lütgert T, Remonda L, Wiest R, Kiefer C, von Känel. Relationship between perceived sleep problems and thalamic size in patients with chronic fatigue syndrome compared to non-fatigued controls: A preliminary study. Clinical Medicine Insights: Psychiatry 2008:1 7-15.
55. Kleinlogel H, Strik W, Begré S. Increased NoGo-anteriorisation in first-episode schizophrenia patients during Continuous Performance Test. Clin Neurophysiol. 2007 Dec;118(12):2683-91.
56. Begré S, Frommer A, von Känel R, Kiefer C, Federspiel A. Relation of white matter anisotropy to visual memory in 17 healthy subjects. Brain Res. 2007 Sep 7;1168:60-6.
57. Federspiel A, Begré S, Kiefer C, Schroth G, Strik WK, Dierks T. Alterations of white matter connectivity in first episode schizophrenia. Neurobiol Dis. 2006 Jun;22(3):702-9.
58. Begré S, Federspiel A, Kiefer C, Schroth G, Dierks T, Strik WK. Reduced hippocampal anisotropy related to anteriorization of alpha EEG in schizophrenia. Neuroreport 2003; 14:739-742.
59. Begré S, von Bardeleben U, Ladewig D, Jaquet-Rochat S, Cosendai-Savary L, Golay KP, Kosel M, Baumann P, Eap CB. Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers. J Clin Psychopharmacol 2002; 22:211-215.
60. Laederach-Hofmann K, Begré S, Bunzel B. Integration process and organ related fantasies in patients undergoing organ transplantation. Psychother Psychosom Med Psychol 2002: 52, 32-40.
61. Begré S, Ladewig D. Soziale Phobie als komorbide Störung bei Abhängigkeitserkrankungen, Schweiz Arch Neurol Psych 2000; 151:93-99.
62. Laederach-Hofmann K, Muhlethaler K, Begré S. Layman constructs, medical diagnosis and changes during one year in psychosomatic outpatients. Psychother Psychosom Med Psychol 1999:49(11), 438-39.
63. Radanov BP, Begré S, Sturzenegger M, Augustiny KF. Course of psychological variables in Whiplash injury – a 2-year follow-up with age, gender and education pair-matched patients, Pain 1996; 64:429-434.

Übersichtsarbeiten

1. Begré S (Gasthrsg.). Therapeutische Umschau (2019), 76(5).
2. Begré S. Die Seele berühren – Energiepsychologie in der Psychosomatik. Therapeutische Umschau (2019), 76(5): 252-260.
3. Begré S. Abklärungsalgorhythmus und versicherungsrelevante Überlegungen. InFo Neurologie & Psychiatrie; Vol. 13, Nr. 1/2015.
4. Cámara RJA, Begré S, von Känel R. Der Effekt stressreduzierender Interventionen auf chronisch entzündliche Darmerkrankungen: Qualitätskontrolle von 10 therapeutischen Z Psychosom Med Psychother. 2010;56(2):116-135.
5. Pittet V, Juillerat P, Mottet C, Felley C, Ballabeni P, Burnand B, Michetti P, Vader JP; Swiss IBD Cohort Study Group. Int J Epidemiol. 2009 Aug ;38(4) :922-31. Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).
6. Camara R, Ziegler R, Begré S, von Känel R. The Role of Psychological Stress in Inflammatory Bowel Disease: Quality Assessment of Methods of 18 Prospective Studies and Suggestions for Future Research. Digestion. 2009;80(2):129-39. Epub 2009 Aug 4.
7. Begré S, Koenig T. Cerebral Disconnectivity: An Early Event in Schizophrenia. Neuroscientist. 2008; 14(1): 19-45. Epub 2007 Oct 2.

Editorials

1. von Känel R, Begré S. Depression after myocardial infarction: unraveling the mystery of poor cardiovascular prognosis and role of beta-blocker therapy. J Am Coll Cardiol. 2006 Dec 5;48(11):2215-7.
2. Begré S. Editorial. Therapeutische Umschau (2019), 76(5).
3. Jordi SBU, Misselwitz B, Begré S. Type D Personality and its Relatonship with Depression and Disease Activity in Inflammatory Bowel Disease – authors’ reply. Aliment Pharmacol Ther. 2021 Jul;54(1):82-83.
4. Jordi SBU, Begré S, Misselwitz B. Should a Psychologist Be a Mandatory Component of IBD Consults? Yes-Authors’ Reply. Inflamm Bowel Dis. 2022 Oct 3;28(10):e138-e139

Buchkapitel

1. Begré S. Chronische Schmerzen – Theorie und Praxis. In: Heinz Böker (Hrsg.), Paul Hoff (Hrsg.), Erich Seifritz (Hrsg.): Psychosomatik heute – Psychosomatik in Klinik und Forschung. Bern: Hogrefe: 2019, pp – 197-208.
2. Begré S, von Känel R. Chronisches Müdigkeitssyndrom (Chronic Fatigue Syndrome). In Brähler E, Hoefert WH (Hrsg.): Lexikon der Modernen Krankheiten – Phänomene, Gefahren, Irrtümer. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft Medizinisch Wissenschaftliche Verlagsgesellschaft: 2014, pp. 1-526.
3. Stohler R, Duersteler KM, Stoermer R, Hug I, Seifritz E, Mager R, Begré S, Ladewig D, Mueller-Spahn F, Hock Ch. Epilepsy and Other Central Nervous System Disorders of Patients with Heroin Assisted Treatment. In: Swiss Federal Office of Public Health (SFOPH). Heroin-assisted Treatment, Work in Progress, Verlag Hans Huber, Bern, Göttingen, Toronto, Seattle, 2005: 105-108.
4. Stohler R, Dürsteler KM, Störmer R, Hug I, Seifritz E, Sattler-Mayr J, Mager R, Begré S, Müller-Spahn F, Ladewig D, Hock C. Hämoglobon-Oxygenierung im zerebralen Kortex nach intravenöser Opioid-Applikation. In: Bundesamt für Gesundheit (Ed.) Suchtforschung des BAG 1996–98, Bd. 1: Grundlagenforschung, pp. 44–45. Bern: Bundesamt für Gesundheit.
5. Radanov BP, Begré S, Sturzenegger M, Augustiny KF. Course of psychological variables in whiplash injury. In: Szpalski M., Gunzburg R. (Eds): Whiplash injuries: Current concepts in prevention, diagnosis and treatment of the cervical whiplash syndrome. Philadelphia: Lippincott-Raven 1997, pp. 151-9.

Aktuelle und frühere ad hoc Reviewer- und Gutachtertätigkeiten

Archives of General Psychiatry

Biological Psychiatry

British Medical Journal

Digestion

European Psychiatry

Human Psychopharmacology: Clinical and Experimental

Journal of Affective Disorders

Journal of Psychosomatic Research

Neurobiology of Disease

Neuropsychobiology

Neuropsychopharmacology & Biological

Psychiatry

Neuroscience

Psychosomatic Medicine

Schizophrenia Research

Bundesamt für Gesundheitswesen (BAG)

CPPP Scientific Press

FMS Advisory Board, Robapharm SA

Swiss National Foundation (SNF/FNS)

The Health Research Board of Ireland (HRB)

Gutachter der Dissertationskommission der Universität Bern